Unusually large bids for Nov. 10, 70 calls, and Jan. 12, 70 calls.
Quote from ptrjon:
the company doesn't make money, and if it ever does, it won't be a lot.
If you were a client dying of testicular cancer, would you pay $100,000.00 for approximately 3 months of additional life, where you have to go through a complicated blood transfusion that may have additional risks? ...I wouldn't.
I also won't short this because there's way to many people that love to invest in "exciting" ideas.